Latest ABK Biomedical News & Updates

See the latest news and media coverage for ABK Biomedical. We track all announcements, press releases, and industry mentions in real time, all in one place.

ABK Biomedical

Clinical-stage medical device developer for imageable embolization technologies

abkbiomedical.com

Headquarters: Halifax, Canada
Founded year: 2012
Company type: Private company
Number of employees: 41–50
Industry: Biotechnology & Medical Research

Last updated October 2

Latest news about ABK Biomedical

In short: ABK Biomedical broke ground on an Eye90 plant and raised $35 million to support commercialization.

Company announcements

October 2 ABK Biomedical

ABK Biomedical celebrates construction kickoff of future facility

The company breaks ground on a new GMP manufacturing plant in Ashland for Eye90 liver cancer treatment, partnering with the University of Missouri. Completion is targeted for 2027.

April 8 ABK Biomedical

ABK Biomedical announces manufacturing facility in Ashland

The company and COR Development will build a GMP facility to produce Eye90 microspheres for commercial Y-90 radioembolization, near MURR, enabling scaled supply.

February 24 ABK Biomedical

ABK Biomedical completed enrollment in pivotal ROUTE90 study

The study is the largest prospective FDA IDE trial for Y90 treatment of hepatocellular carcinoma, enrolling 120 patients.

December 5, 2023 ABK Biomedical

ABK Biomedical's Eye90 microspheres granted FDA Breakthrough Device Designation

The designation is for treating unresectable hepatocellular carcinoma and will expedite FDA interactions.

Media coverage

October 15, 2025 BetaKit

ABK Biomedical raises $35 million USD to bring liver cancer treatment to market

Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1 million CAD) in Series D...

September 12, 2022 Fox 31 News

ABK Biomedical announces FDA 510(k) clearance of Easi-Vue™ embolic microspheres for the embolization of arteriovenous malformations and hypervascular tumors

HALIFAX, NS, Sept. 12, 2022 /PRNewswire/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable...

June 20, 2022 PIX11

ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma

HALIFAX, NS, May 30, 2023 /PRNewswire/ - ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable...

April 8, 2019 Yahoo Finance

ABK Biomedical Raises US$35M in Series D Financing

HALIFAX, NS, Oct. 14, 2025 /CNW/ - ABK Biomedical, Inc., an innovative medical device company dedicated to the research, development, and commercialization of advanced imageable...

Never miss news about ABK Biomedical

Track ABK Biomedical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.